Lilly's pancreatic cancer treatment fails late-stage study

Eli Lilly and Co said on Wednesday its experimental pancreatic cancer treatment in combination with a cocktail of chemotherapies did not meet the main goal in a late-stage study.

from Reuters: Health News https://ift.tt/33zTSUj
via IFTTT